Pacific Biosciences of California, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $45M | ↑+13.8% | — | — | — |
| 2025-09-30 | $38M | ↓-3.8% | $-38M | ↑+37.4% | -101.1% |
| 2025-06-30 | $40M | ↑+10.4% | $-42M | ↑+75.8% | -112.8% |
| 2025-03-31 | $37M | ↓-4.3% | $-426M | ↓-445.0% | -1154.5% |
| 2024-12-31 | $39M | ↓-60.6% | — | — | — |
| 2024-09-30 | $40M | ↓-28.2% | $-61M | ↑+9.2% | -160.3% |
| 2024-06-30 | $36M | ↓-24.3% | $-173M | ↓-148.2% | -488.3% |
| 2024-03-31 | $39M | ↓-0.2% | $-78M | ↑+11.2% | -209.6% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$45M
↑+13.8% +$5M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 63 quarters
margin trajectory tells the operating-leverage storyGross Margin↑+11.5pts
37.1%
Operating Margin↑+59.2pts
-101.1%
Net Margin↑+53.1pts
-98.9%
Go deeper
PACB Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyPACB Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics